Please login to the form below

Not currently logged in
Email:
Password:

Former Pfizer VP James Taylor joins INC Research

He was previously VP global clinical trial management at the US pharma firm

INC Research, James TaylorINC Research has appointed Pfizer's former head of clinical trials James Taylor as its new VP, clinical development.

Taylor, who was VP, global clinical trial management at Pfizer, joins the clinical research organisation (CRO) immediately, and will act as the primary liaison between INC Research and its biopharma customers.

It is the second major personnel change during 2013 for INC Research following the appointment of former chief operating officer Jamie Macdonald to CEO in January.

Macdonald commented on the decision to hire Taylor: "Jim is an accomplished leader with global experience across all phases of complex enterprise operations involving the execution of clinical trials."

He added: "Having worked in large pharma for many years, he brings a strong customer perspective, which allows him to anticipate our customers' needs and communicate their requirements more effectively.”

Taylor spent almost a decade at Pfizer, initially serving as VP, worldwide head contracts and outsourcing before assuming his role in clinical trial management.

Prior to joining Pfizer, Taylor served at Sanofi as senior director outsourcing management and he has also held positions at Baxter Healthcare and Omnicare Clincial Research.

12th March 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics